Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype.

Histopathology - 1 May 2012

Jeong Hoiseon, Ryu Young-joon, An Jungsuk, Lee Youngseok, Kim Aeree

Abstract excerpt

AIMS: Epithelial-mesenchymal transition (EMT) is characterized by a loss of epithelial nature and the acquisition of a mesenchymal form. The aim of this study was to assess the role of EMT in human mammary carcinogenesis, by performing immunohistochemical studies of EMT markers with tissue microarrays. METHODS AND RESULTS: A total of 492 cases were evaluated and classified as hormone receptor (HR)-positive type,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cadherins
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Epithelial-Mesenchymal Transition

Share to Immunohistochemistry

Share to Phenotype

Share to Receptor, ErbB-2

Source

Identifiers

PMID: 22439911
DOI: 10.1111/j.1365-2559.2012.04195.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype.PMID 22439911Read ↗

Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression.Semantic proximity Read ↗

Epithelial-Mesenchymal Transition Phenotype Is Associated with Clinicopathological Factors That Indicate Aggressive Biological Behavior and Poor Clinical Outcomes in Invasive Breast CancerSemantic proximity Read ↗

Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland TumorsSemantic proximity Read ↗

Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.Semantic proximity Read ↗

Expression of markers of stem cell characteristics, epithelial-mesenchymal transition, basal-like phenotype, proliferation, and androgen receptor in metaplastic breast cancer and their prognostic impact.Semantic proximity Read ↗

Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.Semantic proximity Read ↗

Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins.Semantic proximity Read ↗

Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.Semantic proximity Read ↗

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.Semantic proximity Read ↗

Clinical Evolution of Epithelial–Mesenchymal Transition in Human CarcinomasSemantic proximity Read ↗

Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.Semantic proximity Read ↗

Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transitionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.